Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Receptors known as
DREG
adhesion molecules on human neutrophils and monocytes provide for homing of these phagocytic leukocytes to sites of inflammation. They mediate the initial adhesive interaction of the leukocytes to vascular endothelial cells and are then shed from the cell surface in response to chemotactic factors and inflammatory mediators. Systemic accumulation of these agents following major injury or
sepsis
may therefore promote shedding of
DREG
receptors from circulating leukocytes and impair their recruitment to sites of inflammation. To test this hypothesis, we have analyzed the expression of
DREG
receptors on neutrophils and monocytes from 25 patients admitted to the Surgical Intensive Care Unit. Receptor expression was measured by flow cytometry of cells stained with murine monoclonal
DREG
-56 anti-
DREG
antibody. For 14 nonseptic patients, mean monocyte positivity for
DREG
was reduced from 64% to 40%. For 11 septic patients, mean neutrophil and monocyte positivity for
DREG
was reduced from 94% to 82% and 64% to 34%, respectively. These results suggest that monocytes are more affected than neutrophils in vivo by conditions expected to stimulate shedding of
DREG
and that
sepsis
promotes shedding of these adherence receptors. Accumulation of
DREG
-negative monocytes in association with
sepsis
may be sufficient to impair their recruitment to inflammatory sites and limit their contribution to host defense against infection and tissue repair.
...
PMID:Down-regulation of homing receptors: a mechanism for impaired recruitment of human phagocytes in sepsis. 203 May 11